Here Are Biotech’s Big Pipeline Disappointments in 2018 - The Motley...

12/18/18

Here Are Biotech’s Big Pipeline Disappointments in 2018  The Motley Fool

Biotech is notorious for clinical trial pipeline failures, and 2018 had its fair share of setbacks in that area. In this clip from The Motley Fool's Industry Focus: ...

[more]